Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.

Add to Collection

2021 Nov Others S Mohan, G Chawla, J Surya… - Indian Journal of …, 2021 - ncbi.nlm.nih.gov 71

Full Author : ['Mohan, Sashwanthi', 'Chawla, Gajendra', 'Surya, Janani', 'Raman, Rajiv']
Journal Title : Indian journal of ophthalmology
Chapter : Section3
Journal Year : 2021
Cited by : 4.0

PURPOSE: Intravitreal anti-vascular endothelial growth factor (VEGF) therapy is the mainstay in the management of center-involving diabetic macular edema (CI-DME). Topical nonsteroidal anti-inflammatory drugs (NSAIDs) have been used to treat CI-DME as wel..... Read More

Keywords : ["intravitreal antivascular endothelial growth factor", "without topical nonsteroidal antiinflammatory", "centreinvolve diabetic macular edema"]
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725128/
Google Scholar Link : https://scholar.google.com/scholar?cites=4779761866133657291&as_sdt=40005&sciodt=0,10&hl=en&num=20

Have a Question?

Intravitreal anti-vascular endothelial growth factor with and without topical non-steroidal anti-inflammatory in centre-involving diabetic macular edema.